Article tools
Author information
Published in Volume 100, Issue 12
J. Clin. Invest. 100(12): 3164-3172 (1997). doi:10.1172/JCI119872.
Copyright © 1997, The American Society for Clinical Investigation

Research Article

Differential regulation of insulin receptor substrates-1 and -2 (IRS-1 and IRS-2) and phosphatidylinositol 3-kinase isoforms in liver and muscle of the obese diabetic (ob/ob) mouse.

N J Kerouz, D Hörsch, S Pons and C R Kahn

Research Division, Joslin Diabetes Center, and Department of Medicine, Harvard Medical School, Boston, Massachusetts 02215, USA.

Intracellular insulin signaling involves a series of alternative and complementary pathways created by the multiple substrates of the insulin receptor (IRS) and the various isoforms of SH2 domain signaling molecules that can interact with these substrates. In this study, we have evaluated the roles of IRS-1 and IRS-2 in signaling to the phosphatidylinositol (PI) 3-kinase pathway in the ob/ob mouse, a model of the insulin resistance of obesity and non-insulin-dependent diabetes mellitus. We find that the levels of expression of both IRS-1 and IRS-2 are decreased approximately 50% in muscle, whereas in liver the decrease is significantly greater for IRS-2 (72%) than for IRS-1 (29%). This results in differential decreases in IRS-1 and IRS-2 phosphorylation, docking of the p85alpha regulatory subunit of PI 3-kinase, and activation of this enzyme in these two insulin target tissues. In ob/ob liver there is also a change in expression of the alternatively spliced isoforms of the regulatory subunits for PI 3-kinase that was detected at the protein and mRNA level. This resulted in a 45% decrease in the p85alpha form of PI 3-kinase, a ninefold increase in the AS53/p55alpha, and a twofold increase in p50alpha isoforms. Thus, there are multiple alterations in the early steps of insulin signaling in the ob/ob mouse, with differential regulation of IRS-1 and IRS-2, various PI 3-kinase regulatory isoforms, and a lack of compensation for the decrease in insulin signaling by any of the known alternative pathways at these levels.


This article Copyright © 1997, The American Society for Clinical Investigation.

Articles that cite this article:

FROM MICE TO MEN: Insights into the Insulin Resistance Syndromes
Sudha B. Biddinger, C. Ronald Kahn
Annu Rev Physiol 68(1):123. doi:10.1146/annurev.physiol.68.040104.124723 [CrossRef]

Brain-derived neurotrophic factor enhances glucose utilization in peripheral tissues of diabetic mice
M. Yamanaka, A. Tsuchida, T. Nakagawa, T. Nonomura, M. Ono-kishino, E. Sugaru, H. Noguchi, M. Taiji
Diabetes Obes Metab 9(1):59. doi:10.1111/j.1463-1326.2006.00572.x [CrossRef]

Complementary roles of IRS-1 and IRS-2 in the hepatic regulation of metabolism
Cullen M. Taniguchi, Kohjiro Ueki, C. Ronald Kahn
J Clin Invest 115(3):718. doi:10.1172/JCI23187 [CrossRef]

Reduced expression of the murine p85α subunit of phosphoinositide 3-kinase improves insulin signaling and ameliorates diabetes
Franck Mauvais-jarvis, Kohjiro Ueki, David A. Fruman, Michael F. Hirshman, Kei Sakamoto, Laurie J. Goodyear, Matteo Iannacone, Domenico Accili, Lewis C. Cantley, C. Ronald Kahn
J Clin Invest 109(1):141. doi:10.1172/JCI13305 [CrossRef]

Brown adipose tissue–specific insulin receptor knockout shows diabetic phenotype without insulin resistance
Carmen Guerra, Paloma Navarro, Angela M. Valverde, Monica Arribas, Jens Brüning, Leslie P. Kozak, C. Ronald Kahn, Manuel Benito
J Clin Invest 108(8):1205. doi:10.1172/JCI13103 [CrossRef]

Acute impairment of insulin signalling by dexamethasone in primary cultured rat skeletal myocytes
Paul D. Brown, Simone Badal, Seian Morrison, Dalip Ragoobirsingh
MOL CELL BIOCHEM 297(1-2):171. doi:10.1007/s11010-006-9344-y [CrossRef]

TFE3 transcriptionally activates hepatic IRS-2, participates in insulin signaling and ameliorates diabetes
Yoshimi Nakagawa, Hitoshi Shimano, Tomohiro Yoshikawa, Tomohiro Ide, Mariko Tamura, Mika Furusawa, Takashi Yamamoto, Noriyuki Inoue, Takashi Matsuzaka, Akimitsu Takahashi
Nat Med 12(1):107. doi:10.1038/nm1334 [CrossRef]

Region-specific mRNA expression of phosphatidylinositol 3-kinase regulatory isoforms in the central nervous system of C57BL/6J mice
Dieter Hörsch, C. Ronald Kahn
J Comp Neurol 415(1):105. doi:10.1002/(SICI)1096-9861(19991206)415:1<105::AID-CNE8>3.0.CO;2-H [CrossRef]

Rodent models for the study of type 2 diabetes in children (juvenile diabesity)
Clayton E. Mathews
Pediatr Diabetes 3(3):163. doi:10.1034/j.1399-5448.2002.30307.x [CrossRef]

CELLULAR FUNCTION OF PHOSPHOINOSITIDE 3-KINASES: Implications for Development, Immunity, Homeostasis, and Cancer
Roy Katso, Klaus Okkenhaug, Khatereh Ahmadi, Sarah White, John Timms, Michael D. Waterfield
annu rev cell dev biol 17(1):615. doi:10.1146/annurev.cellbio.17.1.615 [CrossRef]

Knockout models are useful tools to dissect the pathophysiology and genetics of insulin resistance
Franck Mauvais-jarvis, Rohit N. Kulkarni, C. Ronald Kahn
Clin Endocrinol (Oxf) 57(1):1. doi:10.1046/j.1365-2265.2002.01563.x [CrossRef]

Prostaglandylinositol cyclic phosphate (cPIP): a novel second messenger of insulin action. Comparative analysis of two kinds of ‘insulin mediators’
Pavel N. Shashkin, Heinrich K. Wasner, Heidi K. Ortmeyer, Barbara C. Hansen
Diabetes Metab Res Rev 17(4):273. doi:10.1002/dmrr.218 [CrossRef]

Stat3-induced apoptosis requires a molecular switch in PI(3)K subunit composition
Kathrine Abell, Antonio Bilancio, Richard W. E. Clarkson, Paul G. Tiffen, Anton I. Altaparmakov, Thomas G. Burdon, Tomoichiro Asano, Bart Vanhaesebroeck, Christine J. Watson
Nat Cell Biol 7(4):392. doi:10.1038/ncb1242 [CrossRef]

Alteration in Expression Profiles of a Series of Diabetes-Related Genes in db/db Mice Following Treatment With Thiazolidinediones.
Akiko Suzuki, Toru Yasuno, Hitoshi Kojo, Jiro Hirosumi, Seitaro Mutoh, Yoshitada Notsu
Jpn J Pharmacol 84(2):113. doi:10.1254/jjp.84.113 [CrossRef]

Irbesartan restores the in-vivo insulin signaling pathway leading to Akt activation in obese Zucker rats
Marina C Mu??oz, Danila P Argentino, Fernando P Dominici, Daniel Turyn, Jorge E Toblli
J Hypertens 24(8):1607???1617. doi:10.1097/01.hjh.0000239297.63377.3f [CrossRef]

Phosphatidylinositol 3-kinase p85α regulatory subunit gene PIK3R1 haplotype is associated with body fat and serum leptin in a female twin population
Y. Jamshidi, H. Snieder, X. Wang, M. J. Pavitt, T. D. Spector, N. D. Carter, S. D. O’dell
Diabetologica 49(11):2659. doi:10.1007/s00125-006-0388-z [CrossRef]